Compare ALIS & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALIS | SRTS |
|---|---|---|
| Founded | 2024 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.9M | 67.5M |
| IPO Year | 2025 | 2016 |
| Metric | ALIS | SRTS |
|---|---|---|
| Price | $9.94 | $4.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 47.1K | ★ 76.4K |
| Earning Date | 01-01-0001 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,609,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.85 | $3.03 |
| 52 Week High | $9.95 | $9.08 |
| Indicator | ALIS | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 66.96 |
| Support Level | N/A | $3.65 |
| Resistance Level | N/A | $4.64 |
| Average True Range (ATR) | 0.00 | 0.22 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 0.00 | 76.77 |
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.